Selected research
Industry Growth & Trends
Global Arbidol Industry Growth and Trends Forecast to 2032
Market perspective
The global Arbidol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Arbidol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Arbidol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Arbidol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Arbidol include JSC Pharmstandard, Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD, Shenyang Coupling Biomedical Technology Co., Ltd. and Yichang Tianren Pharmaceutical Co.,Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Arbidol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Arbidol market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arbidol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arbidol.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Arbidol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Arbidol Market by Company
JSC Pharmstandard
Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
Shenyang Coupling Biomedical Technology Co., Ltd.
Yichang Tianren Pharmaceutical Co.,Ltd
Arbidol Segment by Type
Tablet
Capsule
Others
Arbidol Segment by Application
Drug Store
Hospital
Clinics
Others
Arbidol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arbidol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Arbidol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arbidol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arbidol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Arbidol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
- Others
Applications
- Drug Store
- Hospital
- Clinics
- Others
Companies covered
- JSC Pharmstandard
- Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
- Shenyang Coupling Biomedical Technology Co., Ltd.
- Yichang Tianren Pharmaceutical Co.,Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Arbidol Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Arbidol Sales Estimates and Forecasts (2021-2032)
- 1.3 Arbidol Market by Type
- 1.3.1 Tablet
- 1.3.2 Capsule
- 1.3.3 Others
- 1.4 Global Arbidol Market Size by Type
- 1.4.1 Global Arbidol Market Size Overview by Type (2021-2032)
- 1.4.2 Global Arbidol Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Arbidol Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Arbidol Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Arbidol Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Arbidol Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Arbidol Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Arbidol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Arbidol Industry Trends
- 2.2 Arbidol Industry Drivers
- 2.3 Arbidol Industry Opportunities and Challenges
- 2.4 Arbidol Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Arbidol Revenue (2021-2026)
- 3.2 Global Top Players by Arbidol Sales (2021-2026)
- 3.3 Global Top Players by Arbidol Price (2021-2026)
- 3.4 Global Arbidol Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Arbidol Major Company Production Sites & Headquarters
- 3.6 Global Arbidol Company, Product Type & Application
- 3.7 Global Arbidol Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Arbidol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Arbidol Players Market Share by Revenue in 2025
- 3.8.3 2025 Arbidol Tier 1, Tier 2, and Tier 3
4 Arbidol Regional Status and Outlook
- 4.1 Global Arbidol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Arbidol Historic Market Size by Region
- 4.2.1 Global Arbidol Sales in Volume by Region (2021-2026)
- 4.2.2 Global Arbidol Sales in Value by Region (2021-2026)
- 4.2.3 Global Arbidol Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Arbidol Forecasted Market Size by Region
- 4.3.1 Global Arbidol Sales in Volume by Region (2027-2032)
- 4.3.2 Global Arbidol Sales in Value by Region (2027-2032)
- 4.3.3 Global Arbidol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arbidol by Application
- 5.1 Arbidol Market by Application
- 5.1.1 Drug Store
- 5.1.2 Hospital
- 5.1.3 Clinics
- 5.1.4 Others
- 5.2 Global Arbidol Market Size by Application
- 5.2.1 Global Arbidol Market Size Overview by Application (2021-2032)
- 5.2.2 Global Arbidol Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Arbidol Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Arbidol Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Arbidol Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Arbidol Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Arbidol Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Arbidol Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 JSC Pharmstandard
- 6.1.1 JSC Pharmstandard Company Information
- 6.1.2 JSC Pharmstandard Business Overview
- 6.1.3 JSC Pharmstandard Arbidol Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 JSC Pharmstandard Arbidol Product Portfolio
- 6.1.5 JSC Pharmstandard Recent Developments
- 6.2 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD
- 6.2.1 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Company Information
- 6.2.2 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Business Overview
- 6.2.3 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Arbidol Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Arbidol Product Portfolio
- 6.2.5 Shandong Chuangxin Pharmaceutical Research and Development Co.,LTD Recent Developments
- 6.3 Shenyang Coupling Biomedical Technology Co., Ltd.
- 6.3.1 Shenyang Coupling Biomedical Technology Co., Ltd. Company Information
- 6.3.2 Shenyang Coupling Biomedical Technology Co., Ltd. Business Overview
- 6.3.3 Shenyang Coupling Biomedical Technology Co., Ltd. Arbidol Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Shenyang Coupling Biomedical Technology Co., Ltd. Arbidol Product Portfolio
- 6.3.5 Shenyang Coupling Biomedical Technology Co., Ltd. Recent Developments
- 6.4 Yichang Tianren Pharmaceutical Co.,Ltd
- 6.4.1 Yichang Tianren Pharmaceutical Co.,Ltd Company Information
- 6.4.2 Yichang Tianren Pharmaceutical Co.,Ltd Business Overview
- 6.4.3 Yichang Tianren Pharmaceutical Co.,Ltd Arbidol Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Yichang Tianren Pharmaceutical Co.,Ltd Arbidol Product Portfolio
- 6.4.5 Yichang Tianren Pharmaceutical Co.,Ltd Recent Developments
7 North America by Country
- 7.1 North America Arbidol Sales by Country
- 7.1.1 North America Arbidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Arbidol Sales by Country (2021-2026)
- 7.1.3 North America Arbidol Sales Forecast by Country (2027-2032)
- 7.2 North America Arbidol Market Size by Country
- 7.2.1 North America Arbidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Arbidol Market Size by Country (2021-2026)
- 7.2.3 North America Arbidol Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Arbidol Sales by Country
- 8.1.1 Europe Arbidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Arbidol Sales by Country (2021-2026)
- 8.1.3 Europe Arbidol Sales Forecast by Country (2027-2032)
- 8.2 Europe Arbidol Market Size by Country
- 8.2.1 Europe Arbidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Arbidol Market Size by Country (2021-2026)
- 8.2.3 Europe Arbidol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Arbidol Sales by Country
- 9.1.1 Asia-Pacific Arbidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Arbidol Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Arbidol Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Arbidol Market Size by Country
- 9.2.1 Asia-Pacific Arbidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Arbidol Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Arbidol Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Arbidol Sales by Country
- 10.1.1 South America Arbidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Arbidol Sales by Country (2021-2026)
- 10.1.3 South America Arbidol Sales Forecast by Country (2027-2032)
- 10.2 South America Arbidol Market Size by Country
- 10.2.1 South America Arbidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Arbidol Market Size by Country (2021-2026)
- 10.2.3 South America Arbidol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Arbidol Sales by Country
- 11.1.1 Middle East and Africa Arbidol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Arbidol Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Arbidol Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Arbidol Market Size by Country
- 11.2.1 Middle East and Africa Arbidol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Arbidol Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Arbidol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Arbidol Value Chain Analysis
- 12.1.1 Arbidol Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Arbidol Production Mode & Process
- 12.2 Arbidol Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Arbidol Distributors
- 12.2.3 Arbidol Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst